Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi‐institutional study

• Published in: British journal of clinical pharmacology 2024-01, Vol.90 (1), p.146-157
• Main Authors: Saito, Jumpei, Yakuwa, Naho, Hosokawa, Yoshihiko, Hamada, Hiromi, Suzuki, Tomo, Sago, Haruhiko, Kaneko, Kayoko, Yamatani, Akimasa, Murashima, Atsuko
• Format: Article
• Language: English
• Subjects: biologics; breast milk; dry filter paper; lactation; rheumatoid arthritis
• ISSN: 0306-5251; 1365-2125
• DOI: 10.1111/bcp.15876

Aims Information on breastfeeding and safety of biologics in infants is lacking due to difficulties in case collection. We evaluated methods for determining the concentration of biologics in breast milk using a dry filter method that can simplify the collection, storage and transport of breast milk. Methods To generate dried filter paper (DFP) samples, approximately 30 μL of breast milk was placed onto a Whatman 903 card and punched out. After extraction, the supernatant was measured using an enzyme‐linked immunosorbent assay. Three concentrations of each drug were prepared in liquid breast milk (LBM) and DFP samples to determine their stability up to 28 days after storage at 2–8°C or −20°C for LBM and 25 ± 5°C for DFP. LBM and DFP samples were also provided by nursing mothers using biologics during lactation, and drug concentrations in both samples were compared. The agreement between the two measurement methods was confirmed by Bland–Altman analysis. Results Breast milk was provided by 12 mothers who used biologics (tocilizumab, abatacept, etanercept, golimumab, sarilumab and belimumab). The coefficients of variation for within‐run and between‐run precision for the six drugs were within 15% for both LBM and DFP, and accuracy was within 90%–110% of the quality controls. After 28 days, concentrations remained at more than 90%. The difference between the values obtained by each method was within the acceptable range of error (−12.1 to +16.6 ng/mL). Conclusions A method for determining the concentration of biologics using DFP is expected to help improve pharmacotherapy for lactating women.